StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.75−0.26 (-8.80%)

Close on Nov 18, 2026Market cap $53.09MP/E –Yield –

Corbus Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Corbus Pharmaceuticals's price to book ratio was 0.7× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 375.6×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−0.4
2025Dec 31, 20251.1×+0.2
2024Dec 31, 20241.0×−84.7
2023Dec 29, 202385.6×+85.3
2022Dec 30, 20220.3×−0.7
2021Dec 31, 20211.0×−2.5
2020Dec 31, 20203.5×−8.4
2019Dec 31, 201911.9×+4.1
2018Dec 31, 20187.8×−3.4
2017Dec 29, 201711.2×−16.8
2016Dec 30, 201627.9×+22.4
2015Dec 31, 20155.6×−5.4
2014Dec 31, 201411.0×–

More Corbus Pharmaceuticals figures

See a number that looks wrong?